Skip to main content
Clinical Trials/NCT06673485
NCT06673485CompletedNot Applicable

The Effect of Vitamin D and Calcium Supplement on Overall Body Bone Density and Implant Stability in Posterior Maxilla: a Randomized Clinical Trial

Al-Azhar University1 site in 1 country12 target enrollmentStarted: October 2, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
12
Locations
1
Primary Endpoint
The Implant Stability Quotient

Study Overview

Brief Summary

The aim of the study is to evaluate the effect of Vit D and Calcium administration on allogragt bone maturation radiographically and histomorphometercally in maxillary sinus augmentation in cases of D4 bone density.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Patient with residual bone height from 5 : 8 .
  • •Patient with insufficient Vit D levels.
  • •Patient with D4 bone density.

Exclusion Criteria

  • •Patients that have aproporiate amount of Ca and Vit D.
  • •Sinus pathology that precludes routine sinus augmentation.
  • •Heavy smookers patients.
  • •Systemic diseases that interfere with bone maturion.

Arms & Interventions

Group A : Patients received vitamin D and calcium supplementation during the healing period

Experimental
  1. Monthly intramuscular injections of vitamin D3 (300,000 I.U.) for three months, concurrent with six months of oral Maxical vitamin D supplementation post-implant placement.
  2. Daily intake of Maxical calcium carbonate tablets (600 mg elemental calcium) for six months.

Intervention: Patients received vitamin D and calcium supplementation during the healing period (Procedure)

Group B: Patients have not received any nutritional supplementation during the healing period.

Experimental

Intervention: Patients have not received any nutritional supplementation during the healing period. (Procedure)

Outcomes

Primary Outcomes

The Implant Stability Quotient

Time Frame: Immediate post-operative, and 6 Months post-operative

The Implant Stability Quotient (ISQ) will be assessed using the Osstell device, which provides a stability score ranging from 0 ISQ to 100 ISQ. Higher ISQ values indicate greater implant stability, with 0 ISQ representing the lowest stability and 100 ISQ the highest. This measure allows for consistent, objective assessment of implant stability across time points.

Secondary Outcomes

  • DXA Scan(pre-operative, and 6 Months post-operative)
  • Vitamin D serum levels(Pre-operative, and 6 Months post-operative)
  • Calcium Serum Level(Pre-operative, and 6 Months post-operative)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mostafa Sharkawy

Resident at Oral and Maxillofacial Surgery

Al-Azhar University

Study Sites (1)

Loading locations...

Similar Trials